Technique | Overall (n = 771) | Ada East (n = 149) | Ashaiman (n = 164) | Ayawaso (n = 155) | Ga South (n = 140) | Ga West (n = 163) | x2 (p value) |
---|---|---|---|---|---|---|---|
Microscopy | 59.0 (< 0.01) | ||||||
 Positive | 57 (7.4%) | 16 (10.7%) | 10 (6.1%) | 6 (3.9%) | 13 (9.3%) | 12 (7.4%) |  |
 Negative | 714 (92.6%) | 133 (89.3%) | 154 (93.9%) | 149 (96.1%) | 127 (90.7%) | 151 (92.6%) |  |
Rapid diagnostic test | |||||||
 Total RDT+ | 91 (11.8%) | 24 (16.1%) | 14 (8.5%) | 6 (3.9%) | 27 (19.3%) | 20 (12.3%) | 20.0 (< 0.01) |
 PfHRP2+/pLDH+ | 36 (39.6%)a | 9 (37.5%)a | 7 (50.0%)a | 2 (33.3%)a | 10 (37.0%)a | 8 (40.0%)a |  |
 PfHRP2+/pLDH− | 52 (57.1%)a | 13 (51.2%)a | 7 (50.0%)a | 4 (66.7%)a | 17 (63.0%)a | 11 (55.0%)a |  |
 PfHRP2−/pLDH+ | 3 (3.3%)a | 2 (8.3%)a | 0 (0.0%)a | 0 (0.0%)a | 0 (0.0%)a | 1 (5.0%)a |  |
Molecular assays | |||||||
 crDNA-LAMP | 0.71 (0.399) | ||||||
  Positive | 130 (16.9%) | 36 (24.2%) | 23 (14.0%) | 16 (10.3%) | 28 (20.0%) | 27 (16.6%) |  |
  Negative | 641 (84.1%) | 113 (78.5%) | 141 (86.0%) | 139 (89.7%) | 112 (80.0%) | 136 (83.4%) |  |
 pDNA-LAMP | 0.14 (0.707) | ||||||
  Positive | 135 (17.5%) | 38 (25.5%) | 23 (14.0%) | 16 (10.3%) | 30 (21.4%) | 28 (17.2%) |  |
  Negative | 636 (82.5%) | 111 (74.5%) | 141 (86.0%) | 139 (89.7%) | 110 (78.6%) | 135 (82.8%) |  |
 sWGA | |||||||
  Positive | 139 (18.0%) | 37 (24.8%) | 23 (14.0%) | 17 (11.0%) | 31 (22.1%) | 31 (19.0%) |  |
  Negative | 632 (82.0%) | 112 (75.2%) | 141 (86.0%) | 138 (89.0%) | 109 (77.9%) | 132 (81.0%) |  |
Sub-microscopic donor parasitaemia | |||||||
 Rapid diagnostic test | 34 (4.4%) | 8 (5.4%) | 4 (2.4%) | 0 (0.0%) | 14 (10.0%) | 8 (4.9%) | 31.70 (< 0.01) |
 crDNA-LAMP | 73 (9.5%) | 20 (13.4%) | 13 (7.9%) | 10 (6.4%) | 15 (10.7%) | 15 (9.2%) | 1.12 (0.290) |
 pDNA-LAMP | 78 (10.1%) | 22 (14.7%) | 13 (7.9%) | 10 (6.4%) | 17 (12.1%) | 16 (9.8%) | 0.22 (0.638) |
 sWGA | 82 (10.6%) | 21 (14.1%) | 13 (7.9%) | 11 (7.0%) | 18 (12.8%) | 19 (11.6%) |  |